Article info
PDFInterstitial lung disease: clinical
S14 FVC as a surrogate marker for death and hospitalisation in IPF, sarcoid and bronchiectasis clinical trials
Citation
S14 FVC as a surrogate marker for death and hospitalisation in IPF, sarcoid and bronchiectasis clinical trials
Publication history
- First published November 14, 2013.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions